10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||
| ||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBVIE INC. | |||
Ticker: ABBV Fiscal Year: 2021 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 18, 2022) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
Cash flows from operating activities | |||
Net earnings | $ 11,549 | 4,622 | 7,882 |
Adjustments to reconcile net earnings to net cash from operating activities: | |||
Depreciation | 803 | 666 | 464 |
Amortization of intangible assets | 7,718 | 5,805 | 1,553 |
Deferred income taxes | (898) | (2,325) | 122 |
Change in fair value of contingent consideration liabilities | 2,679 | 5,753 | 3,091 |
Stock-based compensation | 692 | 753 | 430 |
Upfront costs and milestones related to collaborations | 1,624 | 1,376 | 490 |
Gain on divestitures | (68) | 0 | (330) |
Stemcentrx impairment | 0 | 0 | 1,030 |
Other, net | 0 | 832 | 43 |
Changes in operating assets and liabilities, net of acquisitions: | |||
Accounts receivable | (1,321) | (929) | (74) |
Inventories | (142) | (40) | (231) |
Prepaid expenses and other assets | (197) | 134 | (225) |
Accounts payable and other liabilities | 1,628 | 1,514 | 97 |
Income tax assets and liabilities, net | (1,290) | (573) | (1,018) |
Cash flows from operating activities | 22,777 | 17,588 | 13,324 |
Cash flows from investing activities | |||
Acquisition of businesses, net of cash acquired | (525) | (38,260) | 0 |
Other acquisitions and investments | (1,377) | (1,350) | (1,135) |
Acquisitions of property and equipment | (787) | (798) | (552) |
Purchases of investment securities | (119) | (61) | (583) |
Sales and maturities of investment securities | 98 | 1,525 | 2,699 |
Other, net | 366 | 1,387 | 167 |
Cash flows from investing activities | (2,344) | (37,557) | 596 |
Cash flows from financing activities | |||
Net change in commercial paper borrowings | 0 | 0 | (699) |
Repayments of other short-term borrowings | 0 | 0 | (3,000) |
Proceeds from issuance of long-term debt | 1,000 | 3,000 | 31,482 |
Repayments of long-term debt and finance lease obligations | (9,414) | (5,683) | (1,536) |
Debt issuance costs | 0 | (20) | (424) |
Dividends paid | (9,261) | (7,716) | (6,366) |
Purchases of treasury stock | (934) | (978) | (629) |
Proceeds from the exercise of stock options | 244 | 209 | 8 |
Payments of contingent consideration liabilities | (698) | (321) | (163) |
Other, net | 24 | 8 | 35 |
Cash flows from financing activities | (19,039) | (11,501) | 18,708 |
Effect of exchange rate changes on cash and equivalents | (97) | (5) | 7 |
Net change in cash and equivalents | 1,297 | (31,475) | 32,635 |
Cash and equivalents, beginning of year | 8,449 | 39,924 | |
Cash and equivalents, end of year | 9,746 | 8,449 | 39,924 |
Other supplemental information | |||
Interest paid, net of portion capitalized | 2,712 | 2,619 | 1,794 |
Income taxes paid | 3,648 | 1,674 | 1,447 |
Supplemental schedule of non-cash investing and financing activities | |||
Issuance of common shares associated with acquisitions of businesses | 0 | 23,979 | 0 |
External Links | |
ABBVIE INC. (ABBV) Fiscal Year 2021 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |